Philippe Amouyal - 13 Nov 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role: Director
Signature: /s/ Philippe J. Amouyal
Issuer symbol: LXRX
Transactions as of: 13 Nov 2023
Net transactions value: +$201,520
Form type: 4
Filing time: 14 Nov 2023, 16:12:48 UTC
Previous filing: 22 Jun 2023
Next filing: 21 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LXRX	Common Stock	Purchase	$201,520	+200,000	+496%	$1.01	240,332	13 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $0.9858 to $1.0400 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Amouyal hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.

Content

This transaction was executed in multiple trades at prices ranging from $0.9858 to $1.0400 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Amouyal hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.